Header Logo

Connection

Mohammed Tikly to Autoantibodies

This is a "connection" page, showing publications Mohammed Tikly has written about Autoantibodies.
Connection Strength

2,592
  1. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients. Afr Health Sci. 2018 Jun; 18(2):295-303.
    View in: PubMed
    Score: 0,589
  2. The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol. 2010 Jun; 29(6):615-8.
    View in: PubMed
    Score: 0,331
  3. Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations. Arthritis Res Ther. 2023 03 08; 25(1):37.
    View in: PubMed
    Score: 0,205
  4. Systemic sclerosis in sub-Saharan Africa: a systematic review. Pan Afr Med J. 2020; 37:176.
    View in: PubMed
    Score: 0,174
  5. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study. Rheumatology (Oxford). 2020 Jul 01; 59(7):1684-1694.
    View in: PubMed
    Score: 0,170
  6. Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2019 01 01; 58(1):149-153.
    View in: PubMed
    Score: 0,153
  7. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients. Rheumatol Int. 2018 Jun; 38(6):993-1001.
    View in: PubMed
    Score: 0,146
  8. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol. 1996 May; 15(3):261-5.
    View in: PubMed
    Score: 0,127
  9. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol. 1996 Mar; 15(2):143-7.
    View in: PubMed
    Score: 0,126
  10. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
    View in: PubMed
    Score: 0,120
  11. Exaggerated circulating Th-1 cytokine response in early rheumatoid arthritis patients with nodules. Cytokine. 2012 Nov; 60(2):561-4.
    View in: PubMed
    Score: 0,098
  12. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther. 2011; 13(5):R160.
    View in: PubMed
    Score: 0,093
  13. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm. 2010; 2010:158514.
    View in: PubMed
    Score: 0,089
  14. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0,038
  15. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLoS One. 2016; 11(10):e0163894.
    View in: PubMed
    Score: 0,033
  16. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2016 07; 75(7):1285-92.
    View in: PubMed
    Score: 0,030
  17. Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013; 2013:183653.
    View in: PubMed
    Score: 0,026
  18. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis. 2012 Mar; 71(3):463-8.
    View in: PubMed
    Score: 0,023
  19. Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies. Ann Rheum Dis. 1990 Feb; 49(2):107-8.
    View in: PubMed
    Score: 0,021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.